Jefferies Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Jefferies Group’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,305	Closed	-$237K	–	2024
2022 Q2	$237K	Buy	+3,305	New	+$242K	﹤0.01%	1234
2022 Q1	–	Sell	-2,243	Closed	-$230K	–	2048
2021 Q4	$230K	Buy	+2,243	New	+$215K	﹤0.01%	1368
2021 Q3	–	Sell	-3,987	Closed	-$357K	–	2102
2021 Q2	$357K	Buy	3,987 +995	+33%	+$84.1K	﹤0.01%	1263
2021 Q1	$227K	Buy	+2,992	New	+$226K	﹤0.01%	1320
2019 Q4	–	Sell	-4,256	Closed	-$226K	–	3128
2019 Q3	$226K	Buy	+4,256	New	+$218K	﹤0.01%	2306
2019 Q2	–	Sell	-4,500	Closed	-$233K	–	2957
2019 Q1	$233K	Buy	+4,500	New	+$218K	﹤0.01%	1889
2018 Q4	–	Sell	-8,201	Closed	-$423K	–	2691
2018 Q3	$423K	Buy	+8,201	New	+$402K	﹤0.01%	1701
2017 Q2	–	Sell	-7,910	Closed	-$363K	–	2665
2017 Q1	$363K	Buy	+7,910	New	+$394K	﹤0.01%	1747

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jefferies Group's SYNH Position: Q3 2022 in Review

Jefferies Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 3,305 shares — an estimated $237K sold.

Jefferies Group first reported a position in SYNH in Q1 2017 and held it in 8 quarters. The position peaked at $423K in Q3 2018. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Jefferies Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Jefferies Group sold 3,305 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $237K.
Jefferies Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 8 quarters.
Jefferies Group's Syneos Health, Inc. Class A Common Stock position peaked at $423K in Q3 2018.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.